Background: Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), the most common dystrophinopathies, require distinct treatments. Corticosteroids are effective for DMD but less so for BMD. Early diagnosis can improve DMD outcomes and prevent BMD overtreatment. However, differentiating them in younger children with mild symptoms is challenging due to overlapping features.
Purpose: To evaluate the performance of multi-parametric quantitative MRI (qMRI) in early differentiation between BMD and DMD, particularly among younger patients in the mild disease stage.
Study Type: Prospective.
Subjects: 121 DMD males (mean age 8.5 ± 1.6 years), 28 BMD males (9.7 ± 3.3 years), and 26 male healthy controls (HCs) (9.4 ± 2.7 years).
Field Strength/sequence: 3.0T/3-point Dixon (fast-spin-echo), T1-mapping (modified-Look-Locker-inversion-recovery), and T2-mapping (balance-steady-state-free-precession).
Assessment: qMRI measurements (fat fraction [FF], T1, and T2) in 18 pelvic and thigh muscles were conducted. A linearized NorthStar ambulatory assessment (NSAA) score was used to evaluate the function status, with a mild functional decline stage defined as a score of 76-100.
Statistical Tests: Mann-Whitney test, Kruskal-Wallis test, and Receiver operating characteristic curves. A P-value < 0.05 was considered statistically significant.
Results: In all subject groups, DMD exhibits significantly higher FF and T2 and lower T1 compared to BMD. The max differences in mean FF, T1, and T2 was 45.29%, 543 ms, and 31.0 ms, respectively. Overall, the area under curve (AUC) values for FF surpassed those for T2 and T1 in the majority of muscles. In the mild subgroup below 10 years old, DMD had significantly higher FF and T1 than BMD. The combination of FF and T1 in gluteus medius, rectus femoris, vastus lateralis, vastus intermedius, vastus medialis, and adductor magnus achieved higher AUCs (0.816-0.957) than FF (0.773-0.862) or T1 (0.701-0.819) in differentiating the two subgroups.
Data Conclusion: Multi-parametric qMRI demonstrates potential as an effective tool for early differentiation between DMD and BMD.
Evidence Level: 2 TECHNICAL EFFICACY: Stage 3.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jmri.29755 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Value of Optical Genome Mapping (OGM) for Diagnostics of Rare Diseases: A Family Case Report.
Balkan J Med Genet
December 2024
Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Optical genome mapping (OGM) is a novel method enabling the detection of structural genomic variants. The method is based on the laser image acquisition of single, labeled, high-molecular-weight DNA molecules and can detect structural genomic variants such as translocations, inversions, insertions, deletions, duplications, and complex structural rearrangements. We aim to present our experience with OGM at the Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Slovenia.
View Article and Find Full Text PDFNanomechanics of cell-derived matrices as a functional read-out in collagen VI-related congenital muscular dystrophies.
J R Soc Interface
March 2025
Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.
Changes in the mechanical properties of the extracellular matrix (ECM) are a hallmark of disease. Due to its relevance, several models have been developed for the ECM, including cell-derived matrices (CDMs). CDMs are decellularized natural ECMs assembled by cells that closely mimic the stromal fibre organization and molecular content.
View Article and Find Full Text PDFMental health conditions, physical functioning, and health-related quality of life in adults with a skeletal dysplasia: a cross-sectional multinational study.
Orphanet J Rare Dis
March 2025
TRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Bjørnemyr, Norway.
Background: This cross-sectional study investigated mental health conditions, physical functioning, and health-related quality of life (HRQOL) in adults with short-statured skeletal dysplasia conditions across three centres; in New York, Newcastle-upon-Tyne and Norway.
Methods: Questionnaires were sent to patients registered at the centres or distributed to adults attending clinics. The questionnaires included demographics, medical history, depression (PHQ-8), anxiety (GAD-7), pain catastrophizing, activities of daily living (HAQ), and HRQOL (SF 36/RAND-36 and PROMIS-29).
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data.
Orphanet J Rare Dis
March 2025
Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France.
Background: Myasthenia gravis (MG) is a rare autoimmune disorder. Several new treatment concepts have emerged in recent years, but access to these treatments varies due to differing national reimbursement regulations, leading to disparities across Europe. This highlights the need for high-quality data collection by stakeholders to establish MG registries.
View Article and Find Full Text PDFPubertal induction therapy in pediatric patients with Duchenne muscular dystrophy.
J Pediatr Endocrinol Metab
March 2025
Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Objectives: We conducted a scoping review and analyzed the medical literature on PubMed to assess any potential short-term and long-term benefits of pubertal induction in patients with DMD.
Content: We identified six articles from our research cumulatively reporting clinical data from 58 pediatric patients with DMD, of age between 12 and 17.7 years.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!